GlassScriptPhysician profile
Larry E Heit
NPI 1750388245
$24,872.54
in general payments reported to CMS, 2019-2025
33 companies · $2,210 in 2025
The $2,210 reported for 2025 was more than what 89% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,352 · 2020: $1,747 · 2021: $5,527 · 2022: $4,776 · 2023: $6,489 · 2024: $2,772 · 2025: $2,210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,380 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Travel and Lodging: $1,015 · Consulting Fee: $1,000 · Entertainment: $57.72 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,380.08 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Travel and Lodging | $1,015.32 |
| Consulting Fee | $1,000.00 |
| Entertainment | $57.72 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $9,430.21 | 2019-2025 | Lensx, Clareon, Clareon Panoptix Pro |
| Johnson & Johnson Surgical Vision, INC. | $7,488.02 | 2019-2025 | Catalys System, Whitestar Signature Pro, Tecnis Simplicity |
| Carl Zeiss Meditec USA, INC. | $1,233.18 | 2022-2023 | Callisto Eye, Lumera 700 |
| Sun Pharmaceutical Industries INC. | $902.33 | 2019-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $793.84 | 2024-2025 | Xdemvy |
| Abbvie INC. | $554.18 | 2022-2025 | |
| Glaukos Corporation | $542.85 | 2020-2025 | Idosetr, Istent Trabecular Micro-Bypass System Model Is3 |
| Rxsight INC | $506.83 | 2022-2025 | Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Novartis Pharmaceuticals Corporation | $505.96 | 2020-2023 | |
| Coopervision INC. | $500.00 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $294.30 | 2023-2025 | Miebo, Ic-8 Apthera Iol, Xiidra |
| Dompe US, INC. | $263.75 | 2022-2025 | Oxervate |
| Eyevance Pharmaceuticals LLC | $247.54 | 2019-2021 | |
| Carl Zeiss Meditec, INC. | $218.86 | 2019-2020 | |
| Allergan, INC. | $166.59 | 2019-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $162.44 | 2024-2025 | Vevye |
| Amgen INC. | $150.76 | 2024-2025 | Tepezza |
| Oyster Point Pharma, INC. | $140.90 | 2022-2025 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $114.88 | 2019-2021 | |
| Quidel Corporation | $95.41 | 2022 | |
| Kala Pharmaceuticals, INC. | $86.21 | 2020-2021 | |
| Thea Pharma INC. | $72.80 | 2022-2023 | |
| Optos, INC. | $57.72 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Aerie Pharmaceuticals, INC. | $53.88 | 2019-2021 | |
| Akorn, INC. | $53.57 | 2020 | |
| Biotissue Holdings INC. | $51.85 | 2021-2024 | |
| Horizon Therapeutics Plc | $39.18 | 2023 | Tepezza |
| Mallinckrodt Hospital Products INC. | $35.28 | 2021 | |
| Shire North American Group INC | $24.85 | 2019 | |
| Ocular Therapeutix, INC. | $22.01 | 2019 | |
| Leadiant Biosciences, INC. | $21.28 | 2025 | Cystaran |
| Sight Sciences, INC. | $20.64 | 2022 | |
| Astellas Pharma US INC | $20.44 | 2024 | Izervay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Heit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.